This issue of RADAR provides an overview of medicines recently revised on the Pharmaceutical Benefits Scheme (PBS) including:
- Nirmatrelvir and ritonavir (Paxlovid®) and molnupiravir (Lagevrio®) for COVID-19 (amended PBS listing)
- Type 2 diabetes mellitus (T2DM) medicines (amended PBS restrictions).
Learn more about RADAR.